The Korean Journal of Pain

  • 제31권1호
  • /
  • Pages.43-49
  • /
  • 2018
  • /
  • 2005-9159(pISSN)
  • /
  • 2093-0569(eISSN)
대한통증학회 (The Korean Pain Society)
권호 표지
DOI QR코드

DOI QR Code

Cytotoxic activity and subset populations of peripheral blood natural killer cells in patients with chronic pain

  • Yoon, Jae Joon (Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School and Hospital) ;
  • Song, Ji A (Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School and Hospital) ;
  • Park, Sue Youn (Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School and Hospital) ;
  • Choi, Jeong Il (Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School and Hospital)
  • 투고 : 2017.11.13
  • 심사 : 2017.12.05
  • 발행 : 2018.01.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Chronic pain reportedly exerts complex effects on immune function. Natural killer (NK) cells are lymphocytes that play a critical role in cellular and innate immunity. This study examined changes in the subset populations and cytotoxic activity of peripheral blood NK cells in patients with chronic pain. Methods: Thirty patients with chronic moderate-to-severe pain (group P) and age-matched pain-free subjects (group NoP) were enrolled. Peripheral whole blood was analyzed for the percentage and expression of NK cell surface markers (CD56 and CD16) by flow cytometry. Cytotoxic activity was assayed by evaluating CD69 expression on $CD3^-/CD56^+NK$ cells. Results: The percentage of NK cells among total lymphocytes was not significantly different between groups P and NoP ($16.3{\pm}9.3$ vs. $20.2{\pm}10.5%$). Likewise, the percentages of two major NK cell subsets, $CD56^{bright}$ and $CD56^{dim}$, were also not significantly different between the two groups. However, the percentage of $CD56^{bright}/CD16^+$ subset, was slightly but significantly increased in group P ($1.0{\pm}0.9%$; P< 0.01) compared with group NoP ($0.5{\pm}0.6%$). The cytotoxicity of NK cells was not different between the two groups, showing similar CD69 expression (P vs. $NoP=29.2{\pm}15.2$ vs. $32.0{\pm}15.0%$). These findings were not influenced by pain intensity, opioid use, or disease causing pain in group P. Conclusions: NK cell cytotoxic activity and major subset populations, with the exception of an increased percentage of the $CD56^{bright}/CD16^+$ subset, are not significantly altered in patients with chronic severe pain.

키워드

참고문헌

  1. Page GG. The immune-suppressive effects of pain. Adv Exp Med Biol 2003; 521: 117-25.
  2. Tennant F. The physiologic effects of pain on the endocrine system. Pain Ther 2013; 2: 75-86. https://doi.org/10.1007/s40122-013-0015-x
  3. Griep EN, Boersma JW, Lentjes EG, Prins AP, van der Korst JK, de Kloet ER. Function of the hypothalamic-pituitaryadrenal axis in patients with fibromyalgia and low back pain. J Rheumatol 1998; 25: 1374-81.
  4. Strittmatter M, Bianchi O, Ostertag D, Grauer M, Paulus C, Fischer C, et al. Altered function of the hypothalamicpituitary-adrenal axis in patients with acute, chronic and episodic pain. Schmerz 2005; 19: 109-16. https://doi.org/10.1007/s00482-004-0330-6
  5. Hannibal KE, Bishop MD. Chronic stress, cortisol dysfunction, and pain: a psychoneuroendocrine rationale for stress management in pain rehabilitation. Phys Ther 2014; 94: 1816-25. https://doi.org/10.2522/ptj.20130597
  6. Webster Marketon JI, Glaser R. Stress hormones and immune function. Cell Immunol 2008; 252: 16-26. https://doi.org/10.1016/j.cellimm.2007.09.006
  7. Phan MT, Chun S, Kim SH, Ali AK, Lee SH, Kim S, et al. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity. Hum Immunol 2017; 78: 103-12.
  8. Mandal A, Viswanathan C. Natural killer cells: in health and disease. Hematol Oncol Stem Cell Ther 2015; 8: 47-55. https://doi.org/10.1016/j.hemonc.2014.11.006
  9. Camous X, Pera A, Solana R, Larbi A. NK cells in healthy aging and age-associated diseases. J Biomed Biotechnol 2012; 2012: 195956.
  10. Greisen J, Hokland M, Grofte T, Hansen PO, Jensen TS, Vilstrup H, et al. Acute pain induces an instant increase in natural killer cell cytotoxicity in humans and this response is abolished by local anaesthesia. Br J Anaesth 1999; 83: 235-40. https://doi.org/10.1093/bja/83.2.235
  11. Boland JW, Pockley AG. Influence of opioids on immune function in patients with cancer pain: from bench to bedside. Br J Pharmacol 2017 [in press].
  12. Ritz BW, Alexander GM, Nogusa S, Perreault MJ, Peterlin BL, Grothusen JR, et al. Elevated blood levels of inflammatory monocytes (CD14+ CD16+ ) in patients with complex regional pain syndrome. Clin Exp Immunol 2011; 164:108-17. https://doi.org/10.1111/j.1365-2249.2010.04308.x
  13. Brennan PC, Graham MA, Triano JJ, Hondras MA, Anderson RJ. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial. J Manipulative Physiol Ther 1994; 17: 219-27.
  14. Landis CA, Lentz MJ, Tsuji J, Buchwald D, Shaver JL. Pain, psychological variables, sleep quality, and natural killer cell activity in midlife women with and without fibromyalgia. Brain Behav Immun 2004; 18: 304-13. https://doi.org/10.1016/j.bbi.2003.11.001
  15. Vines SW, Gupta S, Whiteside T, Dostal-Johnson D, Hummler-Davis A. The relationship between chronic pain, immune function, depression, and health behaviors. Biol Res Nurs 2003; 5: 18-29. https://doi.org/10.1177/1099800403005001002
  16. Sato N, Kikuchi S, Sato K. Quantifying the stress induced by distress in patients with lumbar disc herniation in terms of natural killer cell activity measurements: chromium release assay versus multiparameter flow cytometric assay. Spine (Phila Pa 1976) 2002; 27: 2095-100. https://doi.org/10.1097/00007632-200210010-00004
  17. Dons'koi BV, Chernyshov VP, Osypchuk DV. Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay. J Immunol Methods 2011; 372: 187-95. https://doi.org/10.1016/j.jim.2011.07.016
  18. Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad L, Hals EK, et al. Assessment of pain. Br J Anaesth 2008; 101: 17-24. https://doi.org/10.1093/bja/aen103
  19. Park SK, Choi YS, Choi SW, Song SW. A comparison of three methods for postoperative pain control in patients undergoing arthroscopic shoulder surgery. Korean J Pain 2015; 28: 45-51. https://doi.org/10.3344/kjp.2015.28.1.45
  20. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22: 633-40. https://doi.org/10.1016/S1471-4906(01)02060-9
  21. Bottino C, Moretta L, Moretta A. NK cell activating receptors and tumor recognition in humans. Curr Top Microbiol Immunol 2006; 298: 175-82.
  22. Poli A, Michel T, Theresine M, Andres E, Hentges F, Zimmer J. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 2009; 126: 458-65. https://doi.org/10.1111/j.1365-2567.2008.03027.x
  23. Boland JW, McWilliams K, Ahmedzai SH, Pockley AG. Effects of opioids on immunologic parameters that are relevant to anti-tumour immune potential in patients with cancer: a systematic literature review. Br J Cancer 2014; 111: 866-73. https://doi.org/10.1038/bjc.2014.384

피인용 문헌

  1. Can predictive biomarkers of chronic pain find in the immune system? vol.31, pp.1, 2018, https://doi.org/10.3344/kjp.2018.31.1.1
  2. Suppression of Human Natural Killer Cells by Different Classes of Opioids : vol.128, pp.5, 2018, https://doi.org/10.1213/ane.0000000000004058
  3. Cytotoxic Immunity in Peripheral Nerve Injury and Pain vol.14, pp.None, 2018, https://doi.org/10.3389/fnins.2020.00142